These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 19632790

  • 1. A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
    Wan Y, Ma X, Li X, Yi J.
    Med Hypotheses; 2009 Nov; 73(5):835-7. PubMed ID: 19632790
    [Abstract] [Full Text] [Related]

  • 2. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S, Xu Z, Qian X, Ding Y, Yu L, Liu B.
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [Abstract] [Full Text] [Related]

  • 3. RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells.
    Shen SN, Xu Z, Qian XP, Ding YT, Yu LX, Liu BR.
    Eur J Cancer Care (Engl); 2008 Jul; 17(4):404-11. PubMed ID: 18485013
    [Abstract] [Full Text] [Related]

  • 4. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY, Yang JY, Dou KF, Ma LY, Teng ZH.
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [Abstract] [Full Text] [Related]

  • 5. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
    Kim SK, Nguyen Pham TN, Nguyen Hoang TM, Kang HK, Jin CJ, Nam JH, Chung SY, Choi SJ, Yang DH, Kim YK, Chung IJ, Kim HJ, Lee JJ.
    Ann Hematol; 2009 Nov; 88(11):1113-23. PubMed ID: 19277657
    [Abstract] [Full Text] [Related]

  • 6. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.
    Zhang HM, Zhang LW, Ren J, Fan L, Si XM, Liu WC.
    Cell Immunol; 2006 Feb; 239(2):144-50. PubMed ID: 16814271
    [Abstract] [Full Text] [Related]

  • 7. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R, Aarts T, Hagenbeek A, Hol S, Ebeling S.
    Cytotherapy; 2005 Feb; 7(1):62-73. PubMed ID: 16040385
    [Abstract] [Full Text] [Related]

  • 8. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
    Mason NJ, Coughlin CM, Overley B, Cohen JN, Mitchell EL, Colligon TA, Clifford CA, Zurbriggen A, Sorenmo KU, Vonderheide RH.
    Gene Ther; 2008 Jul; 15(13):955-65. PubMed ID: 18337841
    [Abstract] [Full Text] [Related]

  • 9. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.
    Onaitis MW, Kalady MF, Emani S, Abdel-Wahab Z, Tyler DS, Pruitt SK.
    Surgery; 2003 Aug; 134(2):300-5. PubMed ID: 12947333
    [Abstract] [Full Text] [Related]

  • 10. alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.
    Meng WS, Butterfield LH, Ribas A, Dissette VB, Heller JB, Miranda GA, Glaspy JA, McBride WH, Economou JS.
    Cancer Res; 2001 Dec 15; 61(24):8782-6. PubMed ID: 11751399
    [Abstract] [Full Text] [Related]

  • 11. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
    Park JY, Yoon SH, Kim EK, Yun SO, Park MY, Sohn HJ, Kim TG.
    Immunol Lett; 2008 Feb 15; 116(1):33-40. PubMed ID: 18096249
    [Abstract] [Full Text] [Related]

  • 12. Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
    Kong J, Diao Z, Deng X, Zhong H, Yao W, Hu X.
    Oncol Rep; 2007 Jul 15; 18(1):279-85. PubMed ID: 17549380
    [Abstract] [Full Text] [Related]

  • 13. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
    González-Carmona MA, Märten A, Hoffmann P, Schneider C, Sievers E, Schmidt-Wolf IG, Sauerbruch T, Caselmann WH.
    Liver Int; 2006 Apr 15; 26(3):369-79. PubMed ID: 16584401
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.
    Zhang HM, Zhang LW, Liu WC, Cheng J, Si XM, Ren J.
    Cytotherapy; 2006 Apr 15; 8(6):580-8. PubMed ID: 17148035
    [Abstract] [Full Text] [Related]

  • 15. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K, Teramoto K, Ozaki Y, Sawai S, Tezuka N, Ishida H, Kajino K, Fujino S, Yamauchi A, Taguchi O, Kannagi R, Yokomise H, Ogasawara K.
    Oncol Rep; 2007 Apr 15; 17(4):895-902. PubMed ID: 17342333
    [Abstract] [Full Text] [Related]

  • 16. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
    Diehl L, den Boer AT, Schoenberger SP, van der Voort EI, Schumacher TN, Melief CJ, Offringa R, Toes RE.
    Nat Med; 1999 Jul 15; 5(7):774-9. PubMed ID: 10395322
    [Abstract] [Full Text] [Related]

  • 17. Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
    Zhang L, Zhang H, Liu W, Wang H, Jia J, Si X, Ren J.
    Cell Immunol; 2005 Nov 15; 238(1):61-6. PubMed ID: 16472793
    [Abstract] [Full Text] [Related]

  • 18. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
    Zhang W, Liu J, Wu Y, Xiao F, Wang Y, Wang R, Yang H, Wang G, Yang J, Deng H, Li J, Wen Y, Wei Y.
    Biochem Biophys Res Commun; 2008 Nov 07; 376(1):10-4. PubMed ID: 18725206
    [Abstract] [Full Text] [Related]

  • 19. Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.
    Vollmer CM, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A, Montejo LD, Lee MC, Andrews KJ, McBride WH, Glaspy JA, Economou JS.
    Cancer Res; 1999 Jul 01; 59(13):3064-7. PubMed ID: 10397245
    [Abstract] [Full Text] [Related]

  • 20. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P.
    Cancer Res; 2003 Jun 01; 63(11):2836-43. PubMed ID: 12782589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.